NASDAQ:TRHC Tabula Rasa HealthCare (TRHC) Stock Forecast, Price & News $10.31 0.00 (0.00%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$10.31▼$10.3750-Day Range$7.66▼$10.3352-Week Range$3.15▼$10.37Volume143,628 shsAverage Volume423,415 shsMarket Capitalization$278.99 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Tabula Rasa HealthCare MarketRank™ ForecastAnalyst RatingHold2.40 Rating ScoreUpside/Downside22.4% Downside$8.00 Price TargetShort InterestHealthy3.19% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.80Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.62 out of 5 starsMedical Sector860th out of 963 stocksBusiness Services, Not Elsewhere Classified Industry79th out of 89 stocks 1.2 Analyst's Opinion Consensus RatingTabula Rasa HealthCare has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.00, Tabula Rasa HealthCare has a forecasted downside of 22.4% from its current price of $10.31.Amount of Analyst CoverageTabula Rasa HealthCare has only been the subject of 2 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted3.19% of the float of Tabula Rasa HealthCare has been sold short.Short Interest Ratio / Days to CoverTabula Rasa HealthCare has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tabula Rasa HealthCare has recently decreased by 21.24%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldTabula Rasa HealthCare does not currently pay a dividend.Dividend GrowthTabula Rasa HealthCare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TRHC. Previous Next 2.7 News and Social Media Coverage News SentimentTabula Rasa HealthCare has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Tabula Rasa HealthCare this week, compared to 1 article on an average week.MarketBeat FollowsOnly 1 people have added Tabula Rasa HealthCare to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Tabula Rasa HealthCare insiders have not sold or bought any company stock.Percentage Held by Insiders30.30% of the stock of Tabula Rasa HealthCare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions61.88% of the stock of Tabula Rasa HealthCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Tabula Rasa HealthCare is -2.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tabula Rasa HealthCare is -2.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Tabula Rasa HealthCare (NASDAQ:TRHC) StockTabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services. As of December 31, 2022, it served approximately 150 healthcare organizations. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.Read More TRHC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TRHC Stock News HeadlinesSeptember 20, 2023 | finance.yahoo.comWith 46% ownership, Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) has piqued the interest of institutional investorsSeptember 18, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on Tabula Rasa HealthCare (NASDAQ:TRHC)September 24, 2023 | Chaikin Analytics (Ad)This Stock Could Go Up 66% or More.Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.September 6, 2023 | thestreet.comTabula Rasa HealthCare Inc. NewsAugust 31, 2023 | msn.comTabula Rasa HealthCare (TRHC) Price Target Increased by 23.38% to 10.54August 8, 2023 | markets.businessinsider.comStifel Nicolaus Sticks to Their Hold Rating for Tabula Rasa HealthCare (TRHC)August 8, 2023 | msn.comWilliam Blair Downgrades Tabula Rasa HealthCare (TRHC)August 8, 2023 | markets.businessinsider.comPiper Sandler Reaffirms Their Hold Rating on Tabula Rasa HealthCare (TRHC)September 24, 2023 | Chaikin Analytics (Ad)This Stock Could Go Up 66% or More.Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.August 8, 2023 | markets.businessinsider.comWhy Are Tabula Rasa HealthCare Shares Moving Higher Today?August 8, 2023 | finance.yahoo.comTabula Rasa Healthcare (TRHC) Q2 Earnings and Revenues Surpass EstimatesAugust 8, 2023 | finance.yahoo.comCompared to Estimates, Tabula Rasa Healthcare (TRHC) Q2 Earnings: A Look at Key MetricsAugust 8, 2023 | finance.yahoo.comTabula Rasa agrees to be acquired in $570M all-cash deal, less than a year after pushing out its founderAugust 8, 2023 | finance.yahoo.comWhy Shares of Tabula Rasa HealthCare Are Soaring MondayAugust 7, 2023 | finanznachrichten.deTabula Rasa HealthCare, Inc.: Tabula Rasa HealthCare Reports Second Quarter 2023 Financial ResultsAugust 7, 2023 | seekingalpha.comTabula Rasa going private; will merge with ExactCare PharmacyAugust 7, 2023 | marketwatch.comTabula Rasa Shares Rally Premarket on Private-Equity BuyoutAugust 7, 2023 | markets.businessinsider.comTabula Rasa To Go Private In $570 Mln Deal With Nautic Partners; Stock Up In PremarketAugust 7, 2023 | marketwatch.comNautic Partners to Buy Tabula Rasa HealthCare in $570 Million Deal >TRHCAugust 7, 2023 | finance.yahoo.comTabula Rasa and ExactCare to Combine to Create a Leading, Independent Pharmacy Care Management Company That Services Patients with the Most Complex NeedsAugust 7, 2023 | finance.yahoo.comTabula Rasa HealthCare Reports Second Quarter 2023 Financial ResultsAugust 4, 2023 | benzinga.comEarnings Outlook For Tabula Rasa HealthCareJuly 25, 2023 | finance.yahoo.comTabula Rasa HealthCare Schedules Second Quarter 2023 Earnings Conference CallJune 12, 2023 | finance.yahoo.comTabula Rasa Healthcare (TRHC) Surges 7.8%: Is This an Indication of Further Gains?June 9, 2023 | finance.yahoo.comTabula Rasa HealthCare (NASDAQ:TRHC) adds US$24m to market cap in the past 7 days, though investors from five years ago are still down 89%May 17, 2023 | finance.yahoo.comMountain Empire PACE Signs with TRHC for Expanded ServicesMay 12, 2023 | msn.comSVB Leerink Upgrades Tabula Rasa HealthCare (TRHC)See More Headlines Receive TRHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter. Email Address TRHC Company Calendar Last Earnings8/07/2023Today9/24/2023Next Earnings (Estimated)11/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TRHC CUSIPN/A CIK1651561 Webwww.tabularasahealthcare.com Phone(866) 648-2767FaxN/AEmployees1,027Year FoundedN/APrice Target and Rating Average Stock Price Forecast$8.00 High Stock Price Forecast$10.00 Low Stock Price Forecast$6.00 Forecasted Upside/Downside-22.4%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($3.85) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-147,510,000.00 Net Margins-28.23% Pretax Margin-17.99% Return on EquityN/A Return on Assets-8.80% Debt Debt-to-Equity RatioN/A Current Ratio1.57 Quick Ratio1.47 Sales & Book Value Annual Sales$299.52 million Price / Sales0.93 Cash FlowN/A Price / Cash FlowN/A Book Value($2.10) per share Price / Book-4.91Miscellaneous Outstanding Shares27,060,000Free Float18,857,000Market Cap$278.99 million OptionableOptionable Beta1.60 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Brian W. Adams (Age 41)CEO, Pres & Director Comp: $668.21kMr. Thomas J. Cancro C.F.A. (Age 55)CPA, Chief Financial Officer Comp: $523.42kMr. Michael Greenhalgh BScPharm (Age 61)RPh, COO & Pres of Pharmacy Services Comp: $630.9kMr. Michael Bruno (Age 35)VP, Corp. Controller & Chief Accounting Officer Mr. Bob Sullivan M.S.Chief Technology OfficerMr. Phillip W. Heath MS (Age 57)Chief Admin. Officer Mr. Frank Sparacino C.F.A.CPA, Sr. VP of Investor Relations & Corp. Devel.Mr. Richard W. Rew II (Age 55)Chief Legal Officer & Corp. Sec. Ms. Kathleen D Larkin M.B.A.Chief People OfficerMs. Andrea Carolan Speers M.S. (Age 42)Chief of Staff More ExecutivesKey CompetitorsAugmedixNASDAQ:AUGXAmerican WellNYSE:AMWLNutex HealthNASDAQ:NUTXPhreesiaNYSE:PHRMultiPlanNYSE:MPLNView All CompetitorsInsiders & InstitutionsPortside Wealth Group LLCBought 20,388 shares on 9/1/2023Ownership: 0.075%Osaic Holdings Inc.Bought 3,955 shares on 8/21/2023Ownership: 0.015%Boothbay Fund Management LLCBought 15,346 shares on 8/15/2023Ownership: 0.057%Quarry LPBought 3,885 shares on 8/15/2023Ownership: 0.014%Citadel Advisors LLCSold 1,100 shares on 8/15/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions TRHC Stock - Frequently Asked Questions Should I buy or sell Tabula Rasa HealthCare stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TRHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares. View TRHC analyst ratings or view top-rated stocks. What is Tabula Rasa HealthCare's stock price forecast for 2023? 5 brokerages have issued 12-month price objectives for Tabula Rasa HealthCare's shares. Their TRHC share price forecasts range from $6.00 to $10.00. On average, they predict the company's stock price to reach $8.00 in the next twelve months. This suggests that the stock has a possible downside of 22.4%. View analysts price targets for TRHC or view top-rated stocks among Wall Street analysts. How have TRHC shares performed in 2023? Tabula Rasa HealthCare's stock was trading at $4.95 at the beginning of the year. Since then, TRHC shares have increased by 108.3% and is now trading at $10.31. View the best growth stocks for 2023 here. Are investors shorting Tabula Rasa HealthCare? Tabula Rasa HealthCare saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 763,200 shares, a decrease of 21.2% from the August 15th total of 969,000 shares. Based on an average trading volume of 376,400 shares, the short-interest ratio is presently 2.0 days. Currently, 3.2% of the company's stock are sold short. View Tabula Rasa HealthCare's Short Interest. When is Tabula Rasa HealthCare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023. View our TRHC earnings forecast. How were Tabula Rasa HealthCare's earnings last quarter? Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) released its earnings results on Monday, August, 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.24. The firm earned $90.04 million during the quarter, compared to analyst estimates of $88.82 million. What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO? 24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Tabula Rasa HealthCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX). When did Tabula Rasa HealthCare IPO? (TRHC) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers. What is Tabula Rasa HealthCare's stock symbol? Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC." Who are Tabula Rasa HealthCare's major shareholders? Tabula Rasa HealthCare's stock is owned by a number of retail and institutional investors. Top institutional investors include Wasatch Advisors LP (4.28%), Kent Lake Capital LLC (2.22%), Acadian Asset Management LLC (1.66%), Portside Wealth Group LLC (1.59%), Kennedy Capital Management LLC (1.34%) and Repertoire Partners LP (1.29%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton, Samira Beckwith and Thomas Cancro. View institutional ownership trends. How do I buy shares of Tabula Rasa HealthCare? Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Tabula Rasa HealthCare's stock price today? One share of TRHC stock can currently be purchased for approximately $10.31. How much money does Tabula Rasa HealthCare make? Tabula Rasa HealthCare (NASDAQ:TRHC) has a market capitalization of $278.99 million and generates $299.52 million in revenue each year. The company earns $-147,510,000.00 in net income (profit) each year or ($3.85) on an earnings per share basis. How many employees does Tabula Rasa HealthCare have? The company employs 1,027 workers across the globe. How can I contact Tabula Rasa HealthCare? Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The official website for the company is www.tabularasahealthcare.com. The company can be reached via phone at (866) 648-2767 or via email at tabularasa@westwicke.com. This page (NASDAQ:TRHC) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tabula Rasa HealthCare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.